July 12, 2024 – Talk Bio

Actionable Insights Powered by AI

FDA Rejects Novo Nordisk’s Once-Weekly Insulin Icodec for Diabetes Treatment

10 months ago talkbio0Tagged Complete, Diabetes, Diabetes Mellitus, Non-Insulin-Dependent, Icodec, Insulin, Nordisk, Response process, United States Food and Drug Administration, Weekly

FDA, Novo Nordisk, Icodec, Weekly Insulin, Diabetes Treatment, Type 1 Diabetes, Type 2 Diabetes, Complete Response Letter

Pfizer Advances Development of Once-Daily Oral GLP-1 Receptor Agonist Danuglipron for Obesity Treatment

10 months ago talkbio0Tagged Clinical Trials, Danuglipron, Drug Formulation Process, Glucagon-Like Peptide-1 Receptor, Obesity, once-daily, Pfizer, Weight Loss Medication

Pfizer, Danuglipron, GLP-1 Receptor Agonist, Obesity Treatment, Once-Daily Formulation, Clinical Trials, Weight Loss Medication

Novartis to Wind Down San Diego Technical Research and Development Site by Mid-2025

10 months ago talkbio0Tagged development aspects, layoffs, Novartis, restructuring, San Diego, Technical Research and

Novartis, San Diego, Technical Research and Development, Site Closure, Layoffs, Restructuring

Ipsen Licenses Second ADC via $1B Bet on Foreseen Bio Asset

10 months ago talkbio0Tagged Antibody-Drug Conjugates, Billion, Ipsen

Ipsen, Foreseen Biotechnology, Antibody-Drug Conjugate (ADC), Licensing Agreement, $1 Billion Deal